In the whole clinical trial process, Firmicutes showed a change of recovery after decreasing first and then increasing, Bacteroidetes showed little change, and Proteobacteria showed an increasing trend after decreasing.
← all excerpts
Prudent Use of Tylosin for Treatment of <i>Mycoplasma gallisepticum</i> Based on Its Clinical Breakpoint and Lung Microbiota Shift.
1
—
—